Axon shows strong growth and minimal dilution risk after $1B convertible note, raising 2024 revenue guidance.

Axon reported a strong 35% year-over-year revenue growth in Q2 FY26 and raised its 2024 revenue guidance to 32-34%, driven by robust software momentum. The company issued a $1 billion 0% convertible note with minimal dilution risk, as dilution is capped unless the stock price exceeds $1,049.94 by 2031. This convertible note structure, along with capped calls and cash settlement options, provides strategic capital flexibility and protects shareholders. Axon trades at 32 times FY28 earnings per share with a projected 27% annual EPS growth, supporting a bullish outlook and significant upside potential for investors.

Axon trades at USD 450.00 on Pluang, up 0.50% as of Sep 21, 2026 18:01 WIB. The stock's market cap stands at $36.37 billion with a 52-week high of $777.58. Investors hold Axon for an average of 17 days on the platform, reflecting active trading interest.